Good question. My guess is the efficacy (at reducing symptomatic disease) of the PFE/BNTX and MRNA vaccines in an all-comers trial conducted right now would fall somewhere in between the original JNJ number and the original PFE/BNTX and MRNA numbers.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.